HOME >> BIOLOGY >> NEWS
Researchers identify two potential protein targets for new drug therapies for pancreatic cancer

Researchers at Fox Chase Cancer Center in Philadelphia have identified two proteins in pancreatic cancer that may be potential targets for new, more specific drug therapies against this deadly disease. Medical oncologist Steven J. Cohen, M.D., presented the study today at the 40th Annual Meeting of the American Society of Clinical Oncology in New Orleans.

Cohen and his colleagues have identified increased levels of two enzymes, FAP (fibroblast activation protein) and FAK (focal adhesion kinase) in tumor samples and surrounding tissue of pancreatic adenocarcinoma specimens.

Fibroblast activation protein appears on connective tissue, or stromal fibroblasts, supporting the foundation (stroma) of various organs in the intestinal tract. This protein enhances the ability of a tumor to grow. Focal adhesion kinase not only promotes cell growth but also helps tumor cells migrate.

"Our hypothesis was that FAP and FAK would be overexpressed in pancreatic cancer and contribute to poor outcome," Cohen explained.

The researchers analyzed 29 tumor specimens from patients who had curative surgery, comparing them to normal and borderline tumor samples. Pancreatic cancer is characterized by a dense surrounding desmoplasia, or inflammatory reaction, which they hypothesized may contribute to the poor outcome in this disease. The role of FAP and FAK in cell growth and migration made them natural subjects for investigation.

"We found that FAP is overexpressed in over 90 percent of pancreatic adenocarcinomas, with greater expression in the fibroblasts surrounding the tumor than in the distant stroma," Cohen said. "Normal pancreas specimens did not have any FAP expression. "FAK was expressed in all tumor specimens and to a greater degree than in distant stroma. In the stromal tissue, there was a modest correlation between overexpression of FAK and FAP. This suggests that interaction between these proteins may contribute
'"/>

Contact: Karen C. Mallet
k_carter@fccc.edu
215-728-2700
Fox Chase Cancer Center
5-Jun-2004


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/11/2019)... , ... November 11, 2019 , ... ... in microbial identification, played a key role in the award-winning study “Next Generation ... the Rothman Institute. The molecular diagnostic laboratory processed samples using Next Generation DNA ...
(Date:11/9/2019)... ... November 08, 2019 , ... ... leading provider of specialized histology, pathology, biomarker development, and archiving services for ... by the mergers of Histo-Scientific Research Laboratories (HSRL), Vet Path Services (VPS) ...
(Date:11/6/2019)... ... 2019 , ... NDA Partners Chairman Carl Peck, MD ... expertise in clinical pharmacology and pharmacometrics and a widely recognized expert in systems ... the firm as an Expert Consultant. , Dr. Stanski has served in senior ...
Breaking Biology News(10 mins):
(Date:10/30/2019)... ... October 30, 2019 , ... ... showcase the many roles innovation and technology play in educating the next generation ... featured hands-on learning opportunities and presentations by WesternU administrators and representatives of companies ...
(Date:10/29/2019)... ... October 29, 2019 , ... Modality Solutions, a ... cold chain validation workshop at the Biomanufacturing World Summit (BMWS19) Conference, November 11-12, ... The Biomanufacturing World Summit brings together pharmaceutical executives, cutting-edge technology providers, ...
(Date:10/26/2019)... ... 24, 2019 , ... Sparks Marketing Group, Inc. (Sparks) ... a boutique healthcare-specific marketing firm, to strengthen the agency’s growing focus on the ... Healthcare clients in pharma, bio-therapeutics, medical device and healthcare technologies currently account for ...
(Date:10/22/2019)... ... October 22, 2019 , ... Catalent, a global leader in clinical supply services, ... Integration, will participate in a panel session titled “Cell and Gene Therapy Logistics” at ... Gwen Hotel, Chicago, on Oct. 28-30, 2019. , The panel session, on Wednesday, Oct. ...
Breaking Biology Technology:
Cached News: